Kasurinen, A. (2020) “Tumor-associated trypsin inhibitor (TATI) and tumor-associated trypsin-2 (TAT-2) predict outcomes in gastric cancer”, Acta Oncologica, 59(6), pp. 681–688. doi: 10.1080/0284186X.2020.1733655.